Homology Medicines, Inc.

📍 Bedford, United States🗓 Founded 2015👥 94 employees💰 Last funded Jul 2017
Biotechnology Research🌐 homologymedicines.com
Website LinkedIn
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2016–2017 · investors recorded per year
2016120172
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Homology Medicines, Inc.?
Homology Medicines, Inc. has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Homology Medicines, Inc. last raise funding?
The most recent investment in Homology Medicines, Inc. recorded on gritt.io was in July 2017.
When was Homology Medicines, Inc. founded?
Homology Medicines, Inc. was founded in 2015.
What industry is Homology Medicines, Inc. in?
Homology Medicines, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Homology Medicines, Inc. based?
Homology Medicines, Inc. is headquartered in Bedford, United States.